Barclays analyst Andrew Lazar raised the firm’s price target on BellRing Brands (BRBR) to $85 from $79 and keeps an Overweight rating on the shares. The firm continues to believe shares have a “sweet journey” ahead, with the company having a lengthy runway of incremental growth opportunity, predicated on both gaining a fair share of shelf and convenient nutrition category trends. From a profitability perspective, the analyst also called out that even with Whey protein costs now expected to stay higher for longer, BellRing still raised its FY25 EBITDA outlook by $10M at the midpoint, and even hinted at Q2 EBITDA that exceeds current consensus estimates.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRBR:
- BellRing Brands raises FY25 revenue view to $2.26B-$2.34B from $2.24B-$2.32B
- BellRing Brands reports Q1 adjusted EPS 58c, consensus 48c
- Bellring Brands Inc Class A (BRBR) Q1 Earnings Cheat Sheet
- BellRing Brands price target raised to $90 from $83 at Citi
- BellRing Brands price target raised to $86 from $83 at TD Cowen